NURTEC ODT (Pfizer Australia Pty Ltd)
Product name
NURTEC ODT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
159 (175 working days)
Active ingredients
rimegepant sulfate
Registration type
NCE/NBE
Indication
NURTEC ODT is indicated for
- acute treatment of migraine with or without aura in adults;
- prophylactic treatment of episodic migraine in adults who have at least 4 migraine attacks per month.